Wuhan : how the COVID-19 outbreak in Wuhan, China spiralled out of control / Dali L. Yang.

By:

Yang, Dali L [author.]

Publisher: New York, NY : Oxford University Press, 2024Copyright date: 2024Description: xv, 392 pages ; 25 cmContent type:

text
still image

Media type:

unmediated

Carrier type:

volume

ISBN:

9780197756263

Subject(s):

Genre/Form:

Print books.

Additional physical formats: Online version:: WuhanLOC classification:

RA644.C67 Y37 2024

Summary: "Dali L. Yang's Fateful Choices offers a penetrating study of China's management of the COVID-19 outbreak in Wuhan, a momentous event that has reverberated globally as the severe pandemic in a century. Yang's work sheds light on the advantage Chinese health decision-makers had, including access to the novel coronavirus's genomic sequences from several laboratories, as early as the end of December 2019. It was at this time that an emergency action program was initiated to combat the burgeoning outbreak in Wuhan"--

Item type:

BOOKS

Average rating: 0.0 (0 votes)

Holdings ( 1 )
Title notes ( 2 )

Holdings
Current library	Home library	Call number	Status	Barcode
Alfaisal University On Shelf	Alfaisal University On Shelf	RA644.C67 Y37 2024 (Browse shelf(Opens below))	Available	AU00000000021324

Total holds: 0

Browsing Alfaisal University shelves, Shelving location: On Shelf Close shelf browser (Hides shelf browser)

Previous								Next
Previous	RA644.C67 S68 2022 Preventable :	RA644.C67 V85 2020 Vulnerable	RA644.C67 W47 2022 The invisible siege :	RA644.C67 Y37 2024 Wuhan : how the COVID-19 outbreak in Wuhan, China spiralled out of control /	RA644.C67 Z4313 2020 Covid-19 :	RA644.C67 Z59 2020 Pandemic! :	RA644.E26 P74 2019 Crisis in the red zone :	Next

Includes bibliographical references and index.

"Dali L. Yang's Fateful Choices offers a penetrating study of China's management of the COVID-19 outbreak in Wuhan, a momentous event that has reverberated globally as the severe pandemic in a century. Yang's work sheds light on the advantage Chinese health decision-makers had, including access to the novel coronavirus's genomic sequences from several laboratories, as early as the end of December 2019. It was at this time that an emergency action program was initiated to combat the burgeoning outbreak in Wuhan"--